Sustained complete remission of extranodal NK/T-cell lymphoma, nasal type, following pembrolizumab and radiation therapy

J Dtsch Dermatol Ges. 2020 Sep;18(9):1019-1021. doi: 10.1111/ddg.14142. Epub 2020 Jun 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Lymphoma, Extranodal NK-T-Cell* / drug therapy
  • Lymphoma, Extranodal NK-T-Cell* / radiotherapy
  • Nose Neoplasms* / drug therapy
  • Nose Neoplasms* / radiotherapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • pembrolizumab